Group 1 - The core viewpoint of the articles highlights the performance and recognition of Kangtai Medical, showcasing its growth in revenue and profit, as well as its recent awards for product design [1][2] Group 2 - As of May 12, Kangtai Medical's stock closed at 13.87 yuan, with a 2.14% increase, a price-to-book ratio of 3.02, and a total market capitalization of 5.573 billion yuan [1] - By the first quarter of 2025, three institutions held shares in Kangtai Medical, including two funds and one other entity, with a total holding of 3.3463 million shares valued at 0.046 billion yuan [1] - The company specializes in the research, production, and sales of medical diagnostic and monitoring equipment, covering various categories such as blood oxygen, electrocardiogram, ultrasound, monitoring, and blood pressure [1] - In April 2023, Kangtai Medical's Remoltar remote professional color Doppler ultrasound diagnostic system won the German IF Design Award and the Italian A Design Award [1] - In October 2023, the company's children's infrared thermometer won the silver award for design innovation at the 2023 Canton Fair, while its respiratory trainer and dynamic electrocardiogram monitor won bronze awards [1] - The latest performance report for the first quarter of 2025 shows that the company achieved operating revenue of 112 million yuan, a year-on-year increase of 12.77%, and a net profit of 16.4358 million yuan, a year-on-year increase of 277.67%, with a gross profit margin of 58.15% [1] Group 3 - Kangtai Medical's PE (TTM) is -84.67, and its PE (static) is -71.54, with a price-to-book ratio of 3.02, compared to the industry average PE of 49.84 and a price-to-book ratio of 4.61 [2] - The industry median PE is 36.59, with a price-to-book ratio of 2.43, indicating that Kangtai Medical's valuation metrics are significantly lower than the industry averages [2]

5月6日，康泰医学今日收盘13.92元，上涨2.35%，最新市净率3.03，创20天以来新低，总市值55.93亿 元。 股东方面，截至2025年3月31日，康泰医学股东户数31459户，较上次减少1578户，户均持股市值35.28 万元，户均持股数量2.76万股。 康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。产品涵盖 血氧类、心电类、超声类、监护类、血压类等多个大类,建立了完善的研发、生产和销售体系。2023年4 月，公司Remoltar远程专业彩色多普勒超声诊断系统荣获德国IF设计奖和意大利A设计奖。2023年10 月，公司的儿童红外体温计产品斩获2023年广交会设计创新奖银奖，呼吸训练器、动态心电监护仪两款 产品斩获铜奖。 最新一期业绩显示，2025年一季报，公司实现营业收入1.12亿元，同比12.77%；净利润1643.58万元， 同比277.67%，销售毛利率58.15%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)9康泰医学-84.98-71.803.0355.93亿行业平均 48.9047.004.53103.78亿行业中值36.4137.242 ...

Group 1 - The core business of Kangtai Medical is the research, production, and sales of medical diagnostic and monitoring equipment, covering various categories such as blood oxygen, electrocardiogram, ultrasound, monitoring, and blood pressure [1] - As of the first quarter of 2025, Kangtai Medical reported a revenue of 112 million yuan, representing a year-on-year increase of 12.77%, and a net profit of 16.44 million yuan, with a significant year-on-year increase of 277.67% [1] - The company achieved a gross profit margin of 58.15% in its latest earnings report [1] Group 2 - Kangtai Medical's stock closed at 12.41 yuan, down 1.90%, with a latest price-to-book ratio of 2.70 and a total market capitalization of 4.986 billion yuan [1] - The company has three institutional holders, including two funds and one other entity, with a total holding of 3.3463 million shares valued at 4.6 million yuan [1] - In April 2023, Kangtai Medical's Remoltar remote professional color Doppler ultrasound diagnostic system won the German IF Design Award and the Italian A Design Award [1]

4月16日，康泰医学今日收盘12.71元，下跌2.61%，最新市净率2.68，总市值51.07亿元。 资金流向方面，4月16日，康泰医学主力资金净流出396.30万元，近5日总体呈流入状态，5日共流入 131.70万元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)5康泰医学-262.5830.812.6851.07亿行业平均 45.9448.384.71101.41亿行业中值29.6428.792.3545.52亿1天益医疗-2672.56-2672.561.6719.88亿2硕世生 物-1835.15-1835.151.1537.91亿3诺唯赞-549.11-549.112.5299.35亿4博晖创新-335.30-206.443.6951.46亿6华 大基因-197.28215.792.04200.47亿7奥精医疗-108.26-108.261.3819.61亿8睿昂基因-79.59-79.591.2411.51亿 9热景生物-60.65-60.653.33108.69亿10华大智造-52.74-52.743.96315.97亿11中红医疗-48.32-32.870.7743.02 亿 康泰医 ...

资金流向方面，3月26日，康泰医学主力资金净流出153.73万元，近5日总体呈流出状态，5日共流出 1540.84万元。 康泰医学收盘上涨1.65%，最新市净率2.99，总市值 56.86亿元 3月26日，康泰医学今日收盘14.15元，上涨1.65%，最新市净率2.99，总市值56.86亿元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)5康泰医学-292.3334.302.9956.86亿行业平均 45.1449.524.84107.93亿行业中值31.9931.002.4848.44亿1硕世生物-1949.53-1949.531.2340.28亿2诺唯 赞-562.38-562.382.4395.62亿3利德曼-363.03174.161.5426.71亿4博晖创新-300.71-185.143.3146.15亿6华大 基因-221.13241.882.29224.71亿7奥精医疗-121.20-121.201.5421.96亿8睿昂基因-82.72-82.721.2911.96亿9 华大智造-55.10-55.104.14330.13亿10中红医疗-54.40-37.010.8648.44亿1 ...